Author: Bori Jung1,2, Chaeyeon Yang1, Seung-Hwan Lee1,3
Affiliation: <sup>1</sup> Clinical Emotion and Cognition Research Laboratory, Inje University, Goyang, Korea.
<sup>2</sup> Department of Psychology, Sogang University, Seoul, Korea.
<sup>3</sup> Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
Conference/Journal: Clin Psychopharmacol Neurosci
Date published: 2024 Feb 29
Other:
Volume ID: 22 , Issue ID: 1 , Pages: 13-22 , Special Notes: doi: 10.9758/cpn.23.1101. , Word Count: 154
Vagus nerve stimulation (VNS) has been approved as an adjunctive treatment for epilepsy and depression. As the progress of VNS treatment for these neuropsychiatric disorders continues, its applications have expanded to a wide range of conditions, including inflammatory diseases to cognitive dysfunctions. The branches of the vagal nerves directly or indirectly innervate the anatomical structures implicated in these neuropsychiatric conditions, which has led to promising results regarding the effectiveness of VNS. Previous studies investigating the effectiveness of VNS have mostly utilized invasive forms of stimulation. However, current preclinical and clinical research indicates that non-invasive forms of VNS, such as transcutaneous vagus nerve stimulation, hold the promise for treating various neuropsychiatric conditions. This review aims to delve into relevant clinical studies of VNS in various illness states, different methods of VNS, and the potential mechanisms underlying the therapeutic effects in these neuropsychiatric conditions.
Keywords: Depression; Neuropsychiatric disorder; Vagus nerve stimulation; Vagus nerves.
PMID: 38247408 DOI: 10.9758/cpn.23.1101